CXCR2 and non-small cell lung carcinoma: For instance, in non-small-cell lung cancer (NSCLC), CXCL8 triggers endothelial cell activation via its receptors CXCR1 and CXCR2, activating the PI3K and MAPK signaling pathways to promote angiogenesis [20].